- Epidermal Growth Factor Receptor as a Predictor of Tumor Response to Preoperative Chemoradiation in Locally Advanced Gastric Carcinoma +32008 | Faculty of Medicine in Hradec Králové
- Epidermal Growth Factor Receptor as a Predictor of Tumor Response to Preoperative Chemoradiation in Locally Advanced Gastric Carcinoma +12008 | First Faculty of Medicine
- T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly2016 | First Faculty of Medicine
- Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study2023 | Faculty of Medicine in Pilsen
- Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Response Patterns of Recurrent Glioblastomas Treated With Tumor-Treating Fields2014 | First Faculty of Medicine
- Microscopics tumor growth module for ContraCancrum project2010 | Faculty of Mathematics and Physics
- Importance of the Immune System and Immunotherapeutic Options in Malignant Melanoma2015 | Publication without faculty affiliation
- Molecular predictive factors of outcome of radiotherapy in cervical cancer2011 | Faculty of Medicine in Hradec Králové
- Gemcitabine and carboplatin treatment in Patients with relapsing ovarian cancer2009 | Publication without faculty affiliation
- Gemcitabine and carboplatin treatment in Patients with relapsing ovarian cancer2009 | Central Library of Charles University
- When and why to indicate breast cancer radiotherapy after neoadjuvant therapy2019 | Third Faculty of Medicine
- Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma2015 | Third Faculty of Medicine
- Potential of Invariant NKT Cells in Allogeneic Stem Cell TransplantationPublication without faculty affiliation
- Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naive Prostate Cancer: 1-and 2-Year Open-label Follow-up Results2015 | First Faculty of Medicine
- Panitumumab as first-line treatment of colorectal cancer2019 | Publication without faculty affiliation
- Response Pattern and Modeling of Tumor Treating Fields2016 | First Faculty of Medicine
- Experimental Combined Immunotherapy of Tumours with Major Histocompatibility Complex Class I Downregulation2018 | Faculty of Science
- Generation of T cell effectors using tumor cell-loaded dendritic cells for adoptive T cell therapy2016 | Second Faculty of Medicine
- Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial2012 | Second Faculty of Medicine
- Porcine epidermal stem cells as a biomedical model for wound healing and normal/malignant epithelial cell propagation2007 | Publication without faculty affiliation
- Panitumumab in the treatment of colorectal carcinoma2020 | Publication without faculty affiliation
- A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer2008 | Third Faculty of Medicine
- Heat-shock protein expression in leukemia2011 | Third Faculty of Medicine
- Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non-Small-Cell Lung Cancer2009 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Diagnostic criteria for oncocytic renal, neoplasms: a survey of urologic pathologists2017 | Faculty of Medicine in Pilsen